<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03591042</url>
  </required_header>
  <id_info>
    <org_study_id>31/18</org_study_id>
    <nct_id>NCT03591042</nct_id>
  </id_info>
  <brief_title>Universal Transvaginal Cervical Length Screening Program for Prevention of Preterm Birth in Singletons Without Prior Preterm Birth</brief_title>
  <official_title>Universal Transvaginal Cervical Length Screening Program for Prevention of Preterm Birth in Singletons Without Prior Preterm Birth: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federico II University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a non-blinded randomized screening trial of asymptomatic singleton pregnancies
      without prior spontaneous preterm birth who are randomized to either transvaginal ultrasound
      cervical length screening program (i.e. intervention group) or no screening (i.e. control
      group). Women are consented and randomized at the time of their routine anatomy scan between
      18 0/7 and 23 6/7 weeks. Women randomized in the transvaginal ultrasound cervical length
      screening will receive a single transvaginal ultrasound cervical length measurement after the
      anatomy scan. The cervical length will be measured by operators with certification of
      competence in the technique.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 15, 2018</start_date>
  <completion_date type="Anticipated">March 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>preterm birth rate</measure>
    <time_frame>Less than 37 weeks</time_frame>
    <description>either spontaneous or indicated preterm delivery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>preterm birth rate</measure>
    <time_frame>ess than 24, 28, 32, 30, and 34 weeks gestation</time_frame>
    <description>either spontaneous or indicated preterm delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>admission to neonatal intensive care unit</measure>
    <time_frame>time of delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>neonatal death</measure>
    <time_frame>Between birth and 28 days of age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>birth weight</measure>
    <time_frame>time of delivery</time_frame>
    <description>weight of the baby at the time of delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite of adverse perinatal outcomes</measure>
    <time_frame>Between birth and 28 days of age</time_frame>
    <description>Number of neonates who will have at least one of the following: necrotizing enterocolitis (NEC), intraventricular hemorrhage (IVH) (grade 3 or higher), respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), retinopathy (ROP), blood-culture proven sepsis and neonatal death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>perinatal death</measure>
    <time_frame>Between birth and 28 days of age</time_frame>
    <description>either fetal or neonatal mortality</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1334</enrollment>
  <condition>Preterm Birth</condition>
  <arm_group>
    <arm_group_label>cervical length screening</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>cervical length screening</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no screening</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no screening</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>cervical length screening</intervention_name>
    <description>transvaginal ultrasound cervical length</description>
    <arm_group_label>cervical length screening</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria are:

          -  Singleton gestations

          -  No prior SPTB

        Exclusion criteria are:

          -  Multiple gestations

          -  History of SPTB in a prior pregnancy

          -  Rupture of membranes at the time of randomization

          -  Known major fetal structural (i.e. defined as those that are lethal or require
             prenatal or postnatal surgery) or chromosomal abnormality

          -  Fetal death at the time of randomization

          -  Cerclage in situ at the time of randomization

          -  Pessary in situ at the time of randomization

          -  Vaginal bleeding at the time of randomization

          -  Women who are unconscious, severly ill, mentally handicapped, or under the age of 18
             years.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>pregnant women</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Gabriele Saccone</name>
      <address>
        <city>Naples</city>
        <zip>80100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriele Saccone</last_name>
      <phone>0817461111</phone>
      <email>gabriele.saccone.1990@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seconda Universit√† di Napoli Luigi Vanvitelli</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maddalena Morlando</last_name>
      <phone>0817461111</phone>
      <email>madmorlando@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Maddalena Morlando, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>July 5, 2018</study_first_submitted>
  <study_first_submitted_qc>July 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 18, 2018</study_first_posted>
  <last_update_submitted>February 20, 2020</last_update_submitted>
  <last_update_submitted_qc>February 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federico II University</investigator_affiliation>
    <investigator_full_name>Gabriele Saccone</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

